Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Finch Therapeutics Group, Inc. See All Filings	D/A	2020-09-23 15:39:10 UTC
Amount To Be Raised $90,000,000 Associated Brokers / Dealers N/A CIK Number 0001733257 Filed Document 0001733257-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-09-23 15:39:10 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Finch Therapeutics Group, Inc. See All Filings	D	2020-09-17 15:54:04 UTC
Amount To Be Raised $90,000,000 Associated Brokers / Dealers N/A CIK Number 0001733257 Filed Document 0001733257-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-09-17 15:54:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Finch Therapeutics Group, Inc. See All Filings	D/A	2019-07-19 11:08:27 UTC
Amount To Be Raised $53,465,316 Associated Brokers / Dealers N/A CIK Number 0001733257 Filed Document 0001733257-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-07-19 11:08:27 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Finch Therapeutics Group, Inc. See All Filings	D	2019-05-20 10:58:16 UTC
Amount To Be Raised $22,999,996 Associated Brokers / Dealers N/A CIK Number 0001733257 Filed Document 0001733257-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-05-20 10:58:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Finch Therapeutics Group, Inc. See All Filings	D	2018-03-05 14:48:04 UTC
Amount To Be Raised $36,399,996 Associated Brokers / Dealers N/A CIK Number 0001733257 Filed Document 0001733257-18-000001 Exclusions or Exemptions 506c Accepted Date 2018-03-05 14:48:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity